Advanced Tumor Marker Testing
PSA, CA125 & CA19.9 | Expert Cancer Screening in Dubai
अपना अपॉइंटमेंट बुक करें
दुबई में DCDC डायग्नोस्टिक सेंटर की सत्यापित रोगी समीक्षाएं
दुबई हेल्थकेयर सिटी से सत्यापित समीक्षाएं और वास्तविक रोगी कहानियां
मैं इस मेडिकल क्लिनिक से बहुत संतुष्ट हूं। मैंने यहां अपनी पहली गर्भावस्था स्क्रीनिंग करवाई। यह किफायती और बहुत पेशेवर था। रेडियोलॉजिस्ट स्वागत करने वाले, दयालु थे और अनुभव बेहतरीन बनाया।
आइज़ान तोकमानबेतोवा
शुक्रवार रात को घुटने में चोट लगी और रविवार शाम को MRI का अपॉइंटमेंट मिला (रविवार दोपहर को बुक किया)। लगभग 2 मिनट इंतजार किया और 30 मिनट से अधिक में हो गया। टीम अद्भुत, मैत्रीपूर्ण और कुशल थी।
किर्स्टन इवांस
डॉ. ओसामा की टीम कोमल और अद्भुत थी। कहीं और बुरे अनुभव के बाद, यहां मेरी पेल्विक जांच बहुत अधिक पेशेवर थी। बढ़िया रिपोर्ट और बहुत सटीक।
मैरी
Tumor Markers Blood Test in Dubai: PSA, CA125 & CA19.9 Screening
Early detection through accurate cancer marker analysis at DHCC
Focused Panel
PSA, CA125, and CA19.9 — the most validated cancer screening markers
Early Detection
Identify potential malignancies before symptoms develop
Fast Results
Most tumor marker results available within 24-48 hours
Specialist Pathway
Direct referral to oncology, gynaecology, or urology if needed
Cancer remains one of the leading causes of morbidity and mortality in the United Arab Emirates, with prostate, ovarian, and gastrointestinal malignancies accounting for a significant proportion of diagnoses. According to the UAE National Cancer Registry, cancer incidence has risen steadily over the past decade, driven by population growth, changing lifestyles, and increased diagnostic awareness. Tumor marker blood tests play a vital role in the early detection and monitoring of these cancers, offering a non-invasive first step that can prompt timely specialist referral and potentially life-saving intervention.
Tumor markers are substances, usually proteins, produced by cancer cells or by the body in response to cancer. While no single tumor marker provides a definitive cancer diagnosis on its own, these biomarkers are invaluable tools when combined with clinical history, imaging, and physical examination. At DCDC in Dubai Healthcare City, we offer a focused panel of the most clinically validated tumor markers: Total PSA for prostate cancer screening, CA125 for ovarian cancer assessment, and CA19.9 for pancreatic and gastrointestinal cancer evaluation. Each marker serves a distinct clinical purpose and is interpreted within the context of the individual patient.
Focused Panel
PSA, CA125, and CA19.9 — the most validated cancer screening markers
Early Detection
Identify potential malignancies before symptoms develop
Fast Results
Most tumor marker results available within 24-48 hours
Specialist Pathway
Direct referral to oncology, gynaecology, or urology if needed
Tumor Markers Blood Test in Dubai: PSA, CA125 & CA19.9 Screening
Early detection through accurate cancer marker analysis at DHCC
Cancer remains one of the leading causes of morbidity and mortality in the United Arab Emirates, with prostate, ovarian, and gastrointestinal malignancies accounting for a significant proportion of diagnoses. According to the UAE National Cancer Registry, cancer incidence has risen steadily over the past decade, driven by population growth, changing lifestyles, and increased diagnostic awareness. Tumor marker blood tests play a vital role in the early detection and monitoring of these cancers, offering a non-invasive first step that can prompt timely specialist referral and potentially life-saving intervention.
Tumor markers are substances, usually proteins, produced by cancer cells or by the body in response to cancer. While no single tumor marker provides a definitive cancer diagnosis on its own, these biomarkers are invaluable tools when combined with clinical history, imaging, and physical examination. At DCDC in Dubai Healthcare City, we offer a focused panel of the most clinically validated tumor markers: Total PSA for prostate cancer screening, CA125 for ovarian cancer assessment, and CA19.9 for pancreatic and gastrointestinal cancer evaluation. Each marker serves a distinct clinical purpose and is interpreted within the context of the individual patient.
Dr. Hadi Komshi
हमारी Tumor Markers सेवाएं
DCDC दुबई हेल्थकेयर सिटी में व्यापक tumor markers सेवाएं।
PSA Testing
Total PSA for prostate cancer screening and monitoring in men over 40.
CA125 Testing
Ovarian cancer marker for risk assessment, diagnosis support, and treatment monitoring.
CA19.9 Testing
Pancreatic and gastrointestinal cancer marker for evaluation and follow-up.
Comprehensive Cancer Screening Panel
Combined PSA, CA125, and CA19.9 panel for thorough cancer marker evaluation.
सभी सेवाएं DHA-लाइसेंस प्राप्त विशेषज्ञों द्वारा की जाती हैं
Tumor Markers किसे करानी चाहिए?
Tumor marker testing is recommended for individuals with risk factors for cancer, those with symptoms that may suggest malignancy, and patients undergoing cancer treatment monitoring. Your physician may order these tests based on clinical findings, family history, or screening guidelines.
Men over 50, or over 40 with family history of prostate cancer, for PSA screening
Women with pelvic masses, bloating, or family history of ovarian cancer for CA125
Patients with unexplained abdominal pain, weight loss, or jaundice for CA19.9
Individuals with a first-degree relative diagnosed with prostate, ovarian, or pancreatic cancer
Patients with known cancer undergoing treatment for response monitoring
Post-treatment cancer survivors for recurrence surveillance
Why Choose DCDC for Tumor Marker Testing?
MOHAP-licensed laboratory with advanced immunoassay technology, rapid turnaround, and integrated specialist referral pathways for comprehensive cancer screening.
MOHAP Licensed
Accredited diagnostic laboratory with certified tumor marker testing protocols and quality assurance.
Rapid Results
Most tumor marker results ready within 24-48 hours for timely clinical decision-making.
Insurance Support
Direct billing with 20+ insurers. Tumor markers typically covered with physician referral.
Convenient Location
Building 64, Block A in Dubai Healthcare City. Walk-ins welcome with appointment preferred.
Advanced Immunoassay
State-of-the-art analyzers calibrated to international reference standards for reliable results.
Specialist Integration
On-site internists, gynaecologists, and urologists for immediate follow-up of abnormal findings.
आपकी आरामदायक यात्रा
आराम, गति और सटीकता के लिए डिज़ाइन की गई एक सरल, चरण-दर-चरण Tumor स्कैन प्रक्रिया।
Tumor Marker Testing Pricing
दुबई में Tumor की कीमतें सेवा के प्रकार और विभिन्न सेवा प्रकार के बीमा कवरेज के अनुसार भिन्न होती हैं।
- स्कैन प्रकार और कंट्रास्ट की आवश्यकता के अनुसार मूल्य भिन्न होते हैं
- रेफरल और सत्यापन के साथ बीमा कवरेज स्वीकृत
- अनुरोध पर तत्काल उद्धरण के साथ पारदर्शी स्व-भुगतान दरें उपलब्ध
मिनटों में बीमा सत्यापन • कोई छिपी फीस नहीं • व्हाट्सएप पर तेज़ प्रतिक्रिया
रोगी गाइड
What to Expect During Tumor Marker Testing
A simple blood draw with minimal preparation and fast turnaround.
बीमा और स्थान
बीमा भागीदार
- •दुबई में 20+ बीमा प्रदाता दमन, एक्सा, एडीएनआईसी और अन्य सहित
- •पूर्व-प्राधिकरण सहायता और प्रत्यक्ष बिलिंग (जहां लागू हो)
- •कवरेज सत्यापन दुबई हेल्थकेयर सिटी में आपकी अपॉइंटमेंट से पहले
- •पारदर्शी मूल्य निर्धारण tumor markers सेवाओं के लिए कोई छिपी फीस नहीं
दुबई हेल्थकेयर सिटी में हमसे मिलें
डॉक्टर्स क्लिनिक डायग्नोस्टिक सेंटर
बिल्डिंग 64, ब्लॉक A, अल राज़ी मेडिकल कॉम्प्लेक्स, दुबई हेल्थकेयर सिटी, दुबई, संयुक्त अरब अमीरात
ऊद मेठा रोड के पास · बुर दुबई, डाउनटाउन दुबई, बिजनेस बे से आसान पहुंच · मुफ्त समर्पित पार्किंग उपलब्ध
कार्य समय
शनि-गुरु: सुबह 8 बजे - रात 10 बजे | शुक्रवार: सुबह 9 बजे - रात 9 बजे
DCDC में बीमा कैसे काम करता है
कवरेज जांचें
सत्यापित करें कि आपकी योजना Tumor Markers को कवर करती है
रेफरल प्राप्त करें
कुछ बीमाकर्ताओं को जीपी रेफरल की आवश्यकता होती है — हम मार्गदर्शन कर सकते हैं
पूर्व-प्राधिकरण
हम आपके बीमाकर्ता से सीधे पूर्व-प्राधिकरण संभालते हैं
सीधी बिलिंग
कोई अग्रिम भुगतान नहीं — हम आपके बीमाकर्ता को सीधे बिल करते हैं
केवल को-पे
आप क्लिनिक में केवल लागू को-पे का भुगतान करते हैं
कवरेज जांचें
सत्यापित करें कि आपकी योजना Tumor Markers को कवर करती है
रेफरल प्राप्त करें
कुछ बीमाकर्ताओं को जीपी रेफरल की आवश्यकता होती है — हम मार्गदर्शन कर सकते हैं
पूर्व-प्राधिकरण
हम आपके बीमाकर्ता से सीधे पूर्व-प्राधिकरण संभालते हैं
सीधी बिलिंग
कोई अग्रिम भुगतान नहीं — हम आपके बीमाकर्ता को सीधे बिल करते हैं
केवल को-पे
आप क्लिनिक में केवल लागू को-पे का भुगतान करते हैं
आपके विशेषज्ञ
Dr. Hadi Komshi
Specialist Internal Medicine
MD, Specialist Internal Medicine
फ़ारसी · अरबी · अंग्रेज़ी
Conditions and Cancers Assessed Through Tumor Markers
Prostate Cancer
PSA is the primary screening and monitoring marker for prostate cancer, the most common non-skin cancer in men.
Ovarian Cancer
CA125 is used to evaluate suspected ovarian masses, monitor treatment response in diagnosed ovarian cancer, and surveil high-risk women with BRCA mutations or strong family history.
Pancreatic Cancer
CA19.9 supports the diagnosis and monitoring of pancreatic adenocarcinoma, with elevated levels correlating with tumor burden and helping predict surgical resectability.
Colorectal Cancer
CA19.9 may be elevated in colorectal malignancies and is sometimes used alongside CEA for monitoring treatment response and detecting recurrence.
संबंधित सेवाएं
हमारी दुबई हेल्थकेयर सिटी क्लिनिक में उपलब्ध अन्य निदान और परामर्श सेवाओं का अन्वेषण करें।
अक्सर पूछे जाने वाले प्रश्न
दुबई में Tumor Markers के बारे में सामान्य प्रश्न।
Tumor markers are proteins produced by cancer cells or the body in response to cancer, measured through a blood test. They serve four functions: screening at-risk individuals, supporting diagnosis, monitoring treatment effectiveness, and detecting recurrence.
PSA (Prostate Specific Antigen) is produced by normal and cancerous prostate cells. Below 4.0 ng/mL is generally normal; 4.0-10.0 is a grey zone where approximately 25 percent may have cancer; above 10.0 carries higher probability.
CA125 is a protein elevated in ovarian cancer (80 percent of advanced cases) but also in endometriosis, fibroids, PID, and menstruation. It is most useful for evaluating women with persistent bloating, pelvic pain, or difficulty eating, and for monitoring diagnosed ovarian cancer.
CA19.9 is a protein shed by pancreatic and GI cancer cells. Below 37 U/mL is generally normal; above 100 U/mL is associated with pancreatic cancer.
Yes. PSA is elevated by BPH, prostatitis, and cycling.
मुख्य तथ्य
चिकित्सा समीक्षा और निरीक्षण
सभी सेवाएं हमारी MOHAP-मान्यता प्राप्त सुविधा में लाइसेंस प्राप्त चिकित्सा पेशेवरों की देखरेख में प्रदान की जाती हैं।